Table 4 Blind Test Performance for the 33, 21, and LCDT1 Algorithm (Validation Set)
From: Blood test shows high accuracy in detecting stage I non-small cell lung cancer
| Â | Model | ||
|---|---|---|---|
Statistics | Algorithm 33 | Algorithm 21 | LCDT1 Algorithm |
Accuracy | 95.6% (92.4, 97.7%) | 94.3% (90.7, 96.8%) | 95.6% (92.4, 97.7%) |
Sensitivity | 89.1% (78.9, 95.3%) | 89.1% (78.9, 95.3%) | 89.1% (78.9, 95.3%) |
Specificity | 97.7% (94.6, 99.2%) | 96.0% (92.2–98.2%) | 97.7% (94.6, 99.2%) |
Positive Predictive Value (PPV) | 92.5% (83.0, 97.4%) | 87.5% (77.0, 94.2%) | 92.5% (83.0, 97.4%) |
Negative Predictive Value (NPV) | 96.6% (93.1, 98.6%) | 96.5% (93.0, 98.5%) | 96.6% (93.1, 98.6%) |
NSCLC Prevalence | 24.1% | 24.1% | 24.1% |
True Positive (TP) | 49 | 44 | 49 |
True Negative (TN) | 169 | 166 | 169 |
False Positive (FP) | 4 | 6 | 4 |
False Negative (FN) | 6 | 7 | 6 |